MINNEAPOLIS, April 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 ...

Direct detection of viral RNA in human or other animal cells by RNA in situ hybridization (ISH) technology is a powerful tool to establish the etiology and pathogenesis of viral disease. Nucleic ...

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Reveal Biosciences, LLC, a leading preclinical services laboratory for advanced tissue technologies, is pleased to announce the availability of Advanced Cell Diagnostics' (ACD) RNAscope® in situ ...

Enabling Bio-Techne's gold-standard RNAscope ISH technology with Imaging Mass Cytometry detection to accelerate multiomic interrogation of health and disease. "Multiomic spatial imaging using the ...

(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2. The company said it is ...

The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial and morphological tissue context. In this webinar, we will focus on an Integrated Co ...

Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and ...

(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2. The company said it is ...